fantofarone

Known as: 2-isopropyl-1-((4-(3-(N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino)propoxy)benzenesulfonyl))indolizine, Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Neutrophils rapidly undergo spontaneous apoptosis following their release from the bone marrow. Although central to leukocyte… (More)
Is this relevant?
1999
1999
AIMS To investigate the pharmacokinetics of SR 33671, the main active metabolite of the calcium antagonist fantofarone, and the… (More)
Is this relevant?
1998
1998
This study describes the synergistic interaction of two calcium channel blockers, verapamil (VR) and SR33557 or fantofarone (SR… (More)
Is this relevant?
1997
1997
Mibefradil is a novel Ca2+ antagonist acting on both L- and T-type Ca2+ channels, with a ten-fold selectivity for T-type Ca2… (More)
Is this relevant?
1997
1997
Fantofarone is a calcium channel antagonist of a class (sulfone indolizine) that is structurally different from the existing… (More)
Is this relevant?
1995
1995
Publisher Summary This chapter illustrates that despite the growth in interest in calcium blockers, there are comparatively few… (More)
Is this relevant?
1994
1994
SR33557 (fantofarone) and SR33805 are structurally novel calcium antagonists that bind selectively to the alpha 1-subunit of the… (More)
Is this relevant?
1994
1994
Using the fluorescent properties of fantofarone, we have studied the interactions between this novel calcium entry blocker and… (More)
Is this relevant?
1994
1994
We have compared the ability of a new calcium channel-blocking agent, fantofarone (SR 33557), to modify the cardiovascular… (More)
Is this relevant?
1994
1994
The binding of fantofarone, a novel calcium channel antagonist, to cytoplasmic membranes and lipid vesicles has been studied by… (More)
Is this relevant?